Pregled bibliografske jedinice broj: 258093
Synthesis of glucoconjugates with heterocyclic oximes
Synthesis of glucoconjugates with heterocyclic oximes // 10th International Medical Chemical Defense Conference 2006. New strategies in medical protection against organophosphorus compounds : Program/Abstracts / Szinicz, Ladislav (ur.).
München: Bundeswehr Institute of Pharmacology and Toxicology, 2006. str. 227-228 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 258093 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Synthesis of glucoconjugates with heterocyclic oximes
Autori
Odžak, Renata ; Oršulić, Mislav ; Tomić, Srđanka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
10th International Medical Chemical Defense Conference 2006. New strategies in medical protection against organophosphorus compounds : Program/Abstracts
/ Szinicz, Ladislav - München : Bundeswehr Institute of Pharmacology and Toxicology, 2006, 227-228
Skup
10th International Medical Chemical Defense Conference 2006 : New strategies in medical protection against organophosphorus compounds
Mjesto i datum
München, Njemačka, 26.04.2006. - 27.04.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
glucoconjugates; oximes
Sažetak
The heterocyclic parts of these conjugates were quinuclidinium, pyridinium or imidazolium oximes, basic structures of many compounds tested in vitro and in vivo as antidotes in poisoning by organophosphorus (OP) compounds such as pesticides and nerve warfare agents. The OP compounds inhibit the enzyme acetylcholinesterase (AChE), essentially irreversibly. This causes accumulation of acetylcholine (ACh) which is responsible for many toxic effects. An oxime is considered to be an efficient antidote if it has a high reactivation rate constant and if it persists in blood circulation for a long enough period of time. Its toxicity should be low as well. The glucoconjugates on which we report in this work were designed as possible model compounds satisfying these requirements. It was previously found that attachment of a sugar moiety to the oxime derivatives increases the bioavailability of the antidote. Thus, we presume that the sugar moiety might be recognized by sites responsible for sugar transport trough the cell membrane leading to the increased permeability of membranes for the quaternary oximes. Furthermore, the previously reported glucoconjugates were less toxic than non-sugar conjugates, and some of them also displayed higher efficacy.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
Napomena
Toxicology 233 (2007) (1-3) 227-228.
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE